Karen Akinsanya, President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships at Schrodinger, holds 69.96K shares in Schrodinger (Ticker: SDGR), holds ― shares in Nautilus Biotechnolgy (Ticker: NAUT).
What is the percentage of profitable transactions made by Karen Akinsanya?
The percentage of profitable transactions made by Karen Akinsanya is ―.
What is the average return per transaction made by Karen Akinsanya?
The average return per transaction made by Karen Akinsanya is ―.
What stocks does Karen Akinsanya hold?
Karen Akinsanya holds: SDGR, NAUT stocks.
What was Karen Akinsanya’s latest transaction?
Karen Akinsanya latest transaction was an Uninformative Sell of $17.62K.
What was Karen Akinsanya's most profitable transaction?
Karen Akinsanya’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Karen Akinsanya's role in Schrodinger?
Karen Akinsanya's role in Schrodinger is President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.